Christopher Rovaldi
First SEC filing: Feb. 3, 2022 · Latest: Feb. 3, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | KROS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 13, 2024 | KROS | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 16, 2023 | KROS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 6, 2022 | KROS | M | 1,728 | · | · | 8,002 Direct | -17.76% | Disposed | (price as of 2026-10-02) |
| April 6, 2022 | KROS | S 10b5-1 | 1,728 | $65.00 | $112,320 | 0 Direct | -100.00% | Disposed | -82.5% (price as of 2026-10-02) |
| April 6, 2022 | KROS | M | 1,728 | $16.00 | $27,648 | 1,728 Direct | · | Acquired | -29.0% (price as of 2026-10-02) |
| April 1, 2022 | KROS | M | 864 | · | · | 9,730 Direct | -8.16% | Disposed | (price as of 2026-10-02) |
| April 1, 2022 | KROS | S 10b5-1 | 105 | $58.83 | $6,177 | 0 Direct | -100.00% | Disposed | -80.7% (price as of 2026-10-02) |
| April 1, 2022 | KROS | S 10b5-1 | 366 | $57.97 | $21,217 | 105 Direct | -77.71% | Disposed | -80.4% (price as of 2026-10-02) |
| April 1, 2022 | KROS | S 10b5-1 | 287 | $56.89 | $16,327 | 471 Direct | -37.86% | Disposed | -80.0% (price as of 2026-10-02) |
| April 1, 2022 | KROS | S 10b5-1 | 104 | $56.20 | $5,845 | 758 Direct | -12.06% | Disposed | -79.8% (price as of 2026-10-02) |
| April 1, 2022 | KROS | S 10b5-1 | 2 | $54.34 | $109 | 862 Direct | -0.23% | Disposed | -79.1% (price as of 2026-10-02) |
| April 1, 2022 | KROS | M | 864 | $16.00 | $13,824 | 864 Direct | · | Acquired | -29.0% (price as of 2026-10-02) |
| Feb. 1, 2022 | KROS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 13, 2024 | KROS | Employee Stock Option (right to buy) | Common Stock | $56.18 | Feb. 12, 2034 | 150,000 | Acquired |
| Feb. 16, 2023 | KROS | Employee Stock Option (right to buy) | Common Stock | $54.38 | Feb. 15, 2033 | 100,000 | Acquired |
| April 6, 2022 | KROS | Employee Stock Option (right to buy) | Common Stock | $16.00 | April 7, 2030 | 1,728 | Disposed |
| April 1, 2022 | KROS | Employee Stock Option (right to buy) | Common Stock | $16.00 | April 7, 2030 | 864 | Disposed |
| Feb. 1, 2022 | KROS | Employee Stock Option (right to buy) | Common Stock | $49.34 | Jan. 31, 2032 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $539,231 | · | · | $6,125,385 | $297,000 | · | $13,800 | $6,975,416 |
| 2023 | $500,000 | · | · | $3,903,265 | $275,000 | · | $9,900 | $4,688,165 |
| 2022 | $435,352 | · | · | $3,538,605 | $235,000 | · | $38,397 | $4,247,354 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.